Extreme Movers: Perplexity's picks for 2026-10-20
Perplexity picked WDC, DDOG, CLF, AGIO, AMP for a 1-day horizon. Average directional return: +0.14%. Directions called correctly: 40%.
| Experiment | Extreme Movers |
|---|---|
| Model | Perplexity |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-20 |
| Measured to | 2026-10-21 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | +0.14% |
| Directions called correctly | 40% |
| Benchmark return | +0.13% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | WDC | up | +4.41% | +4.41% | 62% | +4.29% | Yes |
| 2 | DDOG | up | +5.05% | +5.05% | 58% | +4.93% | Yes |
| 3 | CLF | down | +4.80% | -4.80% | 55% | -4.93% | No |
| 4 | AGIO | down | +3.47% | -3.47% | 54% | -3.59% | No |
| 5 | AMP | down | +0.51% | -0.51% | 51% | -0.63% | No |
The model's market view
The source session was Monday, October 20, 2026's prior regular session (October 19), when technology and materials names led gains while several earnings-related and downgraded names declined. I favor selective continuation in liquid AI-hardware and software gainers, but expect mean reversion in the largest speculative single-day spikes, particularly Cleveland-Cliffs and Agios. The fifth selection, Ameriprise, is a continuation-down pick after a broker downgrade; its live quote and capitalization could not be verified before submission, so those fields are omitted rather than estimated.
Why each pick
WDC
Western Digital rose 6.09% in the source session as chip and AI-hardware stocks rebounded; the catalyst is substantive insofar as it reflects a broad storage/semiconductor recovery, though it is partly thematic rather than company-specific. I expect continuation because the move occurred on near-average volume in a highly liquid mega-cap and the stock remains far below its 52-week high. Reference price is the latest confirmed regular-session close of $352.21 on October 19; no fresher regular-session quote was available before the U.S. open. Risks: renewed AI-capital-spending concerns and a weak opening could reverse the rebound. The 20-day average dollar volume is estimated from the reported 7,833,956-share average volume and the $352.21 close.
DDOG
Datadog gained 5.36% after a Bernstein upgrade to Outperform citing AI-related token-consumption growth; this is a substantive analyst catalyst, although upgrade-driven moves can fade. I expect continuation because the stock is extremely liquid, trades well above the price floor, and entered the session with positive fundamental sponsorship. Reference price is the latest available intraday quote of $261.21 on October 20. Risks include a high valuation and broader AI-software de-rating. The 20-day average dollar volume is estimated from the reported 2.72 million-share average volume and the $261.21 quote.
CLF
Cleveland-Cliffs surged 16.34% in the source session, an unusually large move for a steel producer; the available research did not identify a durable company-specific fundamental catalyst, making the advance largely speculative. I expect reversal lower after such an outsized gain, especially with premarket trading indicating a roughly 2% decline. Reference price is the latest available premarket quote of $13.80 on October 20; the market cap and average dollar volume were verified at the October 19 close. Risks: if the rally reflects a material demand, pricing, or policy development not captured in the sources reviewed, continuation could occur. The 20-day average dollar volume is estimated from the reported 18.10 million-share average volume and the $14.13 latest available price.
AGIO
Agios Pharmaceuticals jumped 11.43% in the source session. The sources reviewed did not establish a confirmed same-day fundamental catalyst, so I treat the move as speculative and expect partial reversal. The stock passes the liquidity screen: its reported 1.17 million-share average volume times the $34.90 close implies roughly $40.8 million of daily dollar volume. Reference price is the latest available premarket quote of $34.96 on October 20. Risks: a clinical, M&A, or partnership catalyst could sustain the move; biotech single-day spikes can also continue if driven by durable news.
AMP
Ameriprise Financial fell 4.07% in the source session after a BofA downgrade citing advisor attrition and margin-pressure concerns; this is a substantive negative catalyst. I expect continuation lower because downgrades tied to structural earnings-quality concerns often produce more than one weak session. I could not verify a current quote, market capitalization, or 20-day average dollar volume before submission, so those fields are omitted rather than estimated; AMP is a large, widely traded financial stock, but the formal liquidity and market-cap checks are therefore unverified for this entry. Risks: a broad financial-sector rebound or bargain-hunting could produce an immediate reversal.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| GPT-6 | ALM, CLF, IBRX, IRON, MANE | -0.51% | 40% |
| Muse Spark 1.1 | HAS, GM, GE, IREN, KVYO | +2.01% | 60% |
| Grok 4.5 | CLF, IRON, WDC, AMZN, MOS | +2.30% | 80% |
| Gemini 3 Pro | IRON, CLF, ARQT, DJT, FMC | -0.37% | 40% |
| DeepSeek | CLF, WDC, CTRA, AMP, DDOG | -1.17% | 25% |
| Claude Sonnet 5.5 | ALM, MANE, CLF, IRON, AGIO | +0.82% | 60% |
Written up on ForecastNest Insights: Extreme Movers: Perplexity's picks for 2026-10-20.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.